Voglow-GM1 Tablet

Composition of Voglow-GM1 Tablet

Voglow-GM1 Tablet contains Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg). It belongs to the Sulfonylurea, Biguanide and Oral anti-diabetic class of medicines.

Uses of Voglow-GM1 Tablet

Treatment of Type 2 diabetes mellitus

Key benefits

• In Treatment of Type 2 diabetes mellitus Voglow 0.3 GM1 Tablet helps control high blood glucose levels after meals and supports better overall diabetes management. The medicine lowers the risk of serious complications of diabetes
• such as kidney damage
• vision problems
• nerve issues
• and limb loss. It also helps reduce the risk of death from cardiovascular disease in people with type 2 diabetes who already have heart disease. Regular use of Voglow 0.3 GM1 Tablet
• along with a healthy diet and exercise
• supports long-term health and helps you maintain a more stable and active life.

How to take Voglow-GM1 Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Voglow 0.3 GM1 Tablet is to be taken on an empty stomach.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Side effects of Voglow-GM1 Tablet

Most side effects of Voglow-GM1 are mild and settle as the body adjusts. Reported side effects include:

• Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Voglow-GM1 Tablet

Warnings and precautions

If you feel shaky, sweaty, confused or unusually hungry, take sugar, glucose or a sweet drink at once and tell your doctor — these are signs your blood sugar has fallen too low. Do not skip meals while on this medicine — a missed meal is the commonest cause of a low-sugar episode. Carry glucose, sugar or sweets with you, and tell the people you live and work with what a low-sugar episode looks like. Older people and people with kidney trouble are more likely to have low sugar, and may need a smaller dose. Stomach upset is common in the first two weeks and usually settles; taking it with food helps. Tell your doctor before any surgery or a scan that uses contrast dye — this medicine is usually stopped for a short time around them. Stop and seek urgent care if you develop deep rapid breathing, severe weakness, muscle pain or vomiting with cold clammy skin. This is rare but serious. Long-term use can lower vitamin B12, so your doctor may check it from time to time. If a low-sugar episode happens while on an alpha-glucosidase inhibitor such as voglibose or acarbose, use glucose — ordinary sugar and sweets work more slowly. Tell your doctor about any new swelling of the ankles, breathlessness or sudden weight gain.

Do not take Voglow-GM1 if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for type 1 diabetes or for diabetic ketoacidosis. Not for people with severe kidney or liver disease. Not for people with severe kidney disease, severe liver disease, or an acute illness causing dehydration. Not for people who have had diabetic ketoacidosis. Not for people with heart failure, active bladder cancer or unexplained blood in the urine.